UC DIS.CERT. 03/25 RIO1/ DE000HD45VS7 /
09/05/2024 11:45:40 | Var.+0.100 | Denaro13:14:40 | Lettera13:14:40 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
50.520EUR | +0.20% | 50.460 Quantità in denaro: 6,000 |
50.470 Quantità in lettera: 6,000 |
RIO TINTO PLC L... | - - | 28/03/2025 | Call |
GlobeNewswire
13:15
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
13:15
ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference
GlobeNewswire
13:04
Standard Lithium Reports Fiscal Third Quarter 2024 Results, Schedules Investor Update Call
GlobeNewswire
13:01
Nevada Copper Files Financial Statements and MD&A for the Quarter Ended March 31, 2024
GlobeNewswire
13:01
HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire
13:00
Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15
GlobeNewswire
13:00
Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific Officer
GlobeNewswire
13:00
Monte Rosa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
13:00
Lantronix to Participate in the 19th Annual Needham Technology, Media, & Consumer Investor Conferenc...
GlobeNewswire
13:00
First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness ...
GlobeNewswire
13:00
NOWPayments Enables Cryptocurrency Purchases of Tangem Wallets: Expanding Payment Options with BTC, ...